These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11025619)

  • 1. Expression of CD34 by megakaryocytes in myelodysplastic syndromes.
    Pellegrini W; Facchetti F; Marocolo D; Pelizzari AM; Capucci A; Rossi G
    Haematologica; 2000 Oct; 85(10):1117-8. PubMed ID: 11025619
    [No Abstract]   [Full Text] [Related]  

  • 2. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes.
    Tang G; Wang SA; Menon M; Dresser K; Woda BA; Hao S
    Leuk Res; 2011 Jun; 35(6):766-70. PubMed ID: 21367453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of CD7 and terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome.
    Font P; Subirá D; Mtnez-Chamorro C; Castañón S; Arranz E; Ramiro S; Gil-Fernández JJ; López-Pascual J; Alonso A; Pérez-Sáenz MA; Alaez C; Renedo M; Blas C; Escudero A; Fdez-Rañada JM
    Leuk Res; 2006 Aug; 30(8):957-63. PubMed ID: 16417922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome.
    Heinrichs S; Berman JN; Ortiz TM; Kornblau SM; Neuberg DS; Estey EH; Look AT
    Br J Haematol; 2005 Jul; 130(1):83-6. PubMed ID: 15982348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired generation of bone marrow CD34-derived dendritic cells with low peripheral blood subsets in patients with myelodysplastic syndrome.
    Micheva I; Thanopoulou E; Michalopoulou S; Kakagianni T; Kouraklis-Symeonidis A; Symeonidis A; Zoumbos N
    Br J Haematol; 2004 Sep; 126(6):806-14. PubMed ID: 15352984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of CD34
    Duarte FB; DE Jesus Dos Santos TE; Barbosa MC; Moura ATG; DE Vasconcelos JPL; Rocha-Filho FD; Coutinho DF; Zalcberg I; Vasconcelos PRL; Garcia YDO; Lemes RPG
    In Vivo; 2019; 33(1):277-280. PubMed ID: 30587636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
    Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
    Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apoptotic characteristics of CD34 positive cells in myelodysplastic syndromes].
    Li X; Pu Q; Liu YZ; Tao Y; Ying SX; Jiang QY; Shi J
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):355-7. PubMed ID: 12941189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of circulating CD34+ cells in myelodysplastic syndromes.
    Cesana C; Klersy C; Brando B; Nosari A; Scarpati B; Scampini L; Molteni A; Nador G; Santoleri L; Formenti M; Valentini M; Mazzone A; Morra E; Cairoli R
    Leuk Res; 2008 Nov; 32(11):1715-23. PubMed ID: 18456323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical-biological findings.
    Rigolin GM; Porta MD; Bugli AM; Castagnari B; Mauro E; Bragotti LZ; Ciccone M; Cuneo A; Castoldi G
    Eur J Haematol; 2004 Nov; 73(5):351-8. PubMed ID: 15458514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in the study of CD34+ cells in myelodysplastic syndrome].
    Zhang H; Shao Z
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jul; 19(7):387-9. PubMed ID: 11189522
    [No Abstract]   [Full Text] [Related]  

  • 15. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.
    Maratheftis CI; Andreakos E; Moutsopoulos HM; Voulgarelis M
    Clin Cancer Res; 2007 Feb; 13(4):1154-60. PubMed ID: 17317824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes.
    Buccisano F; Maurillo L; Tamburini A; Del Poeta G; Del Principe MI; Ammatuna E; Consalvo MI; Campagna S; Ottaviani L; Sarlo C; Renzi D; Faccia S; Fraboni D; Lo Coco F; Amadori S; Venditti A
    Eur J Haematol; 2008 Feb; 80(2):107-14. PubMed ID: 18028430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.
    Della Porta MG; Malcovati L; Boveri E; Travaglino E; Pietra D; Pascutto C; Passamonti F; Invernizzi R; Castello A; Magrini U; Lazzarino M; Cazzola M
    J Clin Oncol; 2009 Feb; 27(5):754-62. PubMed ID: 19103730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment in immuno-modulatory function of Flk1(+)CD31(-)CD34(-) MSCs from MDS-RA patients.
    Han Q; Sun Z; Liu L; Chen B; Cao Y; Li K; Zhao RC
    Leuk Res; 2007 Nov; 31(11):1469-78. PubMed ID: 17360037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes.
    Satoh C; Dan K; Yamashita T; Jo R; Tamura H; Ogata K
    Leuk Res; 2008 May; 32(5):699-707. PubMed ID: 17936901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.